Lv4
406 积分 2020-10-30 加入
1223P Sex specific efficacy and safety outcomes in operable stage III non-small cell lung cancer (NSCLC): Pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14
3小时前
求助中
[China lymphoma diagnosis and treatment guideline (2026 edition)]
1个月前
已完结
Molecular Profiling across 80,000 Patients with Lung Cancer
3个月前
已完结
Molecular Profiling in Non-Small-Cell Lung Cancer: A Single-Center Study on Prevalence and Prognosis
3个月前
已完结
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
6个月前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
6个月前
已完结
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
10个月前
已完结
皖公网安备34019202002308
